PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
10-Dec-2020 Almac Group Granted Phase I Award Under the ‘Sustainable Innovation Fund’ to Aid COVID-19 Recovery Almac Group
10-Dec-2020 RDIF and RCIF participate in meeting of Intergovernmental Russian-Chinese Commission for Investment Cooperation Russian Direct Investment Fund (RDIF)
10-Dec-2020 ALUNBRIG▼(brigatinib) now available on the NHS in England, Wales and Northern Ireland for adults with ALK-positive advanced non-small cell lung cancer who have not been previously treated with an ALK inhibitor Takeda UK Ltd
10-Dec-2020 Stats show increase in mental health drugs prescribed during pandemic NHS Business Services Authority’s (NHSBSA)
10-Dec-2020 PureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema PureTech Health plc
10-Dec-2020 Atox Bio Announces FDA Acceptance to File the NDA for Reltecimod to Treat Suspected Organ Dysfunction or Failure in Patients with Necrotizing Soft Tissue Infection (“Flesh-Eating Disease”) Atox Bio
10-Dec-2020 Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents Moderna
10-Dec-2020 CPL UK Healthcare (RIG) win back to back framework awards across the NHS. CPL UK Healthcare
09-Dec-2020 Orgenesis signs joint venture with Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies Orgenesis Inc
09-Dec-2020 Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer Evelo Biosciences, Inc
09-Dec-2020 RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer Exact Sciences Corp
09-Dec-2020 Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer Evelo Biosciences, Inc
09-Dec-2020 Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic Dermatitis Evelo Biosciences, Inc
09-Dec-2020 Clasado announces clinician-led gut health digital event for February 2021 Clasado
09-Dec-2020 GENTRONIX EXPANDS SERVICES TO MEET GROWING GLOBAL DEMAND Contract Research Organisation (CRO)
09-Dec-2020 PureTech Founded Entity Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology PureTech Health plc
09-Dec-2020 ISPE Foundation Partners with Gilead Sciences on Internship Program to Diversify the Pharma Industry’s Workforce ISPE Foundation
09-Dec-2020 AlzeCure receives approval to start clinical Phase Ib trial with ACD440 in neuropathic pain AlzeCure Pharma AB
09-Dec-2020 YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY Kite, a Gilead Company
09-Dec-2020 I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China I-Mab